| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | 10% Owner | Director, 10% Owner
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 5 buys and 16 sells.
Estimated insider holdings value: $1510.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2025 | PASG Passage Bio, Inc. | 10% Owner | Sell | 223,219 | $0.64 | $142,223.38 | -1.0% | -35.8% | +27.0% | |
| Jan 8, 2025 | PASG Passage Bio, Inc. | 10% Owner | Sell | 147,024 | $0.70 | $103,305.69 | -0.7% | -50.5% | +39.1% | |
| Dec 20, 2024 | PASG Passage Bio, Inc. | 10% Owner | Sell | 230,321 | $0.60 | $138,192.60 | -3.0% | -27.9% | -27.3% | |
| Dec 11, 2024 | PASG Passage Bio, Inc. | 10% Owner | Sell | 62,276 | $0.83 | $51,988.04 | -0.3% | -45.5% | -29.6% | |
| Dec 6, 2024 | PASG Passage Bio, Inc. | 10% Owner | Sell | 97,103 | $0.80 | $77,338.46 | -0.6% | -39.4% | -40.6% | |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | Director, 10% Owner | Buy | 825,000 | $17.00 | $14,025,000.00 | +16.9% | -50.3% | -5.7% | |
| Sep 19, 2024 | PASG Passage Bio, Inc. | 10% Owner | Sell | 39,300 | $0.71 | $27,903.00 | -0.5% | -12.6% | -48.8% | |
| Sep 18, 2024 | PASG Passage Bio, Inc. | 10% Owner | Sell | 137,031 | $0.73 | $100,032.63 | -0.9% | -4.4% | -46.1% | |
| Sep 16, 2024 | MBX Mbx Biosciences, Inc. | Director, 10% Owner | Buy | 1,000,000 | $16.00 | $16,000,000.00 | +28.9% | -11.6% | -55.0% | |
| Aug 26, 2024 | SPRY Ars Pharmaceuticals, Inc. | Director | Sell | 83,695 | $13.00 | $1,088,035.00 | -100% | +3.9% | +5.2% |